Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ingram

Showing results (361-370 of 507) with videos related to

Pageof 51
Sort By:
Dermatology (Basel, Switzerland)|November 5, 2024
Treatment Satisfaction in Patients with Hidradenitis Suppurativa: A Real-World Survey from the EU5 and USAJohn R Ingram, Vincenzo Bettoli, Jasmine I Espy, et al.
The British Journal of Dermatology|May 23, 2022
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization studyHans Christian Ring, Yiqiu Yao, Julia-Tatjana Maul, et al.
Science (New York, N.Y.)|March 7, 2015
Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptorJohn S Burg, Jessica R Ingram, A J Venkatakrishnan, et al.
Acta Dermato-Venereologica|April 17, 2026
Exploring the Impact of Fatigue and Sleep Disturbance in Hidradenitis Suppurativa: Perspectives from Patients and Healthcare ProfessionalsBarry M McGrath, Donna Atherton, Phil Brady, et al.
International Journal of Antimicrobial Agents|February 25, 2015
Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New ZealandBenjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Journal of the American Academy of Dermatology|September 19, 2021
Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 RegistryHaley B Naik, Raed Alhusayen, John Frew, et al.
Virology|November 15, 1996
Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activityN J Butkiewicz, M Wendel, R Zhang, et al.
Cancer Research|January 23, 2014
Universal marker and detection tool for human sarcoma circulating tumor cellsArun Satelli, Abhisek Mitra, Jeffry J Cutrera, et al.
The British Journal of Dermatology|April 15, 2018
A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi processL Thorlacius, J R Ingram, B Villumsen, et al.
Cancer Research|June 25, 2017
NF1<sup>+/-</sup> Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy ResponseRebecca D Dodd, Chang-Lung Lee, Tess Overton, et al.
Pageof 51

Showing results (361-370 of 507) with videos related to

Sort By:
Pageof 51
Dermatology (Basel, Switzerland)|November 5, 2024
Treatment Satisfaction in Patients with Hidradenitis Suppurativa: A Real-World Survey from the EU5 and USAJohn R Ingram, Vincenzo Bettoli, Jasmine I Espy, et al.
The British Journal of Dermatology|May 23, 2022
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization studyHans Christian Ring, Yiqiu Yao, Julia-Tatjana Maul, et al.
Science (New York, N.Y.)|March 7, 2015
Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptorJohn S Burg, Jessica R Ingram, A J Venkatakrishnan, et al.
Acta Dermato-Venereologica|April 17, 2026
Exploring the Impact of Fatigue and Sleep Disturbance in Hidradenitis Suppurativa: Perspectives from Patients and Healthcare ProfessionalsBarry M McGrath, Donna Atherton, Phil Brady, et al.
International Journal of Antimicrobial Agents|February 25, 2015
Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New ZealandBenjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Journal of the American Academy of Dermatology|September 19, 2021
Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 RegistryHaley B Naik, Raed Alhusayen, John Frew, et al.
Virology|November 15, 1996
Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activityN J Butkiewicz, M Wendel, R Zhang, et al.
Cancer Research|January 23, 2014
Universal marker and detection tool for human sarcoma circulating tumor cellsArun Satelli, Abhisek Mitra, Jeffry J Cutrera, et al.
The British Journal of Dermatology|April 15, 2018
A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi processL Thorlacius, J R Ingram, B Villumsen, et al.
Cancer Research|June 25, 2017
NF1<sup>+/-</sup> Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy ResponseRebecca D Dodd, Chang-Lung Lee, Tess Overton, et al.
Pageof 51